Marc Hasenfuss Editor-at-large

I thought it rather interesting that two of the JSE’s most vaunted "game changers" — asset manager Sygnia and day-clinics developer Advanced Health — both detailed rights issues last week.

The companies need fresh capital for (very) different reasons: Sygnia to fund the recent acquisition of db X-trackers from Deutsche Group Holdings, and Advanced to shore up its strained balance sheet to continue its day clinic roll-out.

BL Premium

This article is reserved for our subscribers.

We have several subscription options to help you enjoy the best of our content every day, including exclusive Financial Times articles, Morningstar financial data and full digital access to The Wall Street Journal.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00.